Accusations of bias prompt NIH review of ethical guidelines

Article Abstract:

The Los Angeles Times have levelled charges against the US National Institutes of Health (NIH) on the basis that various private drugs firms have been paying top scientist additional consulting fees. Due to this allegation the NIH has to reassess its ethics rules, so as to prevent any hindrance in further research.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

The pain game

Article Abstract:

The U.S. Food and Drug Administration's (FDA's) ban on the pain killers like Merck's Arcoxia (etoricoxib), a relative of Vioxx (rofecoxib), has tainted a whole class of new drugs. The impact of this ban on new painkillers is examined.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Patent crunch pending

Article Abstract:

The article discusses the U.S. Patent Reform Act of 2007. The Act is found to be completely in the favor of the IT industries and has proved to be extremely fatal for the drug makers.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: